CXCL16 and glioblastoma: To examine the role of the CXCR6/CXCL16 axis in GBM progression, we implanted CT2A tumors into WT or CXCR6 KO mice, and after 14 days of engraftment, flow cytometry analysis was performed (Figures 3C, D).